Skip to Main Content

Author Details

Paulette Mhawech-Fauceglia
University of Southern California
1995
167
40
PMIDPaper TitleJournal TitlePublished Year
37079977Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer.Gynecol Oncol2023
36195845Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues.Clin Proteomics2022
34529000Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.JAMA Oncol2021
33923934Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer.Cancers (Basel)2021
34944751Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease.Biomedicines2021
29406333A Case Report of an Adenomatoid Tumor of the Uterus Mimicking an Endometrioid Adenocarcinoma on Endometrial Curetting: a Diagnostic Pitfall.Appl Immunohistochem Mol Morphol2020
31711656Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature.Gynecol Oncol2020
32034256Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma.Sci Rep2020
32595827The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers.Oncotarget2020
32701140Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.JAMA Oncol2020
32332753Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.Nat Commun2020
32165999Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma.Oncotarget2020
28800013Metastatic Acinic Cell Carcinoma to the Vagina: A First Reported Case.Appl Immunohistochem Mol Morphol2019
31729966Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.BMC Cancer2019
31658584Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles.Int J Mol Sci2019
31825847A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.Cell Rep2019
28787528Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.J Surg Oncol2018
30105438Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.Ann Surg Oncol2018
29891190Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma.Pathology2018
30217299Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.Surg Oncol2018
29971677Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.Ann Surg Oncol2018
30131975Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.NPJ Breast Cancer2018
30309325Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.BMC Cancer2018
29428179The diagnosis of mucinous lesions in endometrial samplings by gynaecological pathologists: an analysis of diagnostic reproducibility.Pathology2018
29262583Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer.Oncotarget2017
28277338Endometrioid Adenocarcinoma Arising in a Paratubal Cyst: A Case Report and Review of the Literature.Appl Immunohistochem Mol Morphol2017
28456378High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.Gynecol Oncol2017
29312534The PAX8 cistrome in epithelial ovarian cancer.Oncotarget2017
27052653Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.Ann Oncol2016
26598983Microfocus of Anaplastic Carcinoma Arising in Mural Nodule of Ovarian Mucinous Borderline Tumor With Very Rapid and Fatal Outcome.Int J Gynecol Pathol2016
27771165Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response.Gynecol Oncol2016
27526105Targeting Src in endometriosis-associated ovarian cancer.Oncogenesis2016
26916619RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.Nat Commun2016
26718725Nestin: A biomarker of aggressive uterine cancers.Gynecol Oncol2016
25047817NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.Int J Cancer2015
26246197Monocytes play different roles in stimulating T cells in obese diabetic individuals.Int J Immunopathol Pharmacol2015
26428923Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection.J Microbiol2015
26425718Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series.Gynecol Oncol Rep2015
26425710Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor.Gynecol Oncol Rep2015
26238457Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia.Gynecol Oncol2015
26079312PAX8 expression in ovarian surface epithelial cells.Hum Pathol2015
26132201Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.PLoS One2015
26098711DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.Epigenetics2015
25991737Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.J Clin Pathol2015
25955944MOLECULAR FINGERPRINTS OF MIXED ENDOMETRIOID AND SEROUS ADENOCARCINOMA OF THE ENDOMETRIUM: IGCS-0044 Uterine Cancer, including Sarcoma.Int J Gynecol Cancer2015
25684138Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.Oncogene2015
25204737Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.Int J Cancer2015
25331442Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.Cancer Microenviron2015
24214412Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.Cancer Microenviron2014
25101620Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.PLoS One2014
  • 1 - 50 of 167

Recommended Authors

Cathleen Matrai
Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 0
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 1
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Stefan Kommoss
Eberhard Karls University Tubingen
Career Start Year 2005
Number of shared co-authors 11
Michael S Anglesio
University of British Columbia
Career Start Year 2004
Number of shared co-authors 11
Sven Mahner
University Hospital
Career Start Year 2002
Number of shared co-authors 5
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 4
Martin K??bel
University of Calgary
Career Start Year 2001
Number of shared co-authors 14
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 3
Douglas A Levine
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 19
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Naveena Singh
Barts Health NHS Trust
Career Start Year 1993
Number of shared co-authors 9
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 17
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 4
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 4
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 1
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 10
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 6
Gary L Keeney
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 6
Andrew Berchuck
Duke School of Medicine
Career Start Year 1983
Number of shared co-authors 21
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 9
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 3
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 3
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Tanja Pejovic
Oregon Health & Science University
Co-authored papers 29
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 10
Lloyd J Old
Ludwig Institute for Cancer Research
Co-authored papers 7
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 5
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 5
Feng Qian
Co-authored papers 5
Yuesheng Zhang
Co-authored papers 4
Rosario I Corona
Cedars-Sinai Medical Center
Co-authored papers 3
Rita Nanda
Co-authored papers 3
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 3
Judy C Boughey
Mayo Clinic
Co-authored papers 3
Claudine Isaacs
Co-authored papers 3
William F Symmans
Co-authored papers 3
Christina Yau
University of California San Francisco
Co-authored papers 2
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 2
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Co-authored papers 2
Minetta C Liu
Co-authored papers 2
Brian M Feldman
Co-authored papers 2
Teresa Helsten
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Andrew J G Simpson
University of Hull
Co-authored papers 2
Laura J Van't Veer
University of California San Francisco
Co-authored papers 2
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Matthew L Freedman
Dana-Farber Cancer Institute
Co-authored papers 2
Lajos Pusztai
Co-authored papers 2
Donald A Berry
MD Anderson Cancer Center
Co-authored papers 2
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 2
Yao-Tseng Chen
From Population Health Services (Chen)
Co-authored papers 1
Nadja Pejovic
Saint Louis University
Co-authored papers 1
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Release 1.2